Nygaard James P Jr 4

What Happened
James P. Nygaard Jr., Chief Financial Officer of Core Scientific, received an award of 120,074 restricted stock units (RSUs) on May 20, 2026. The grant is reported at $0.00 per share (a standard RSU grant — reported value $0). One‑third of the RSUs vest on March 15, 2027; the remaining two‑thirds vest in eight substantially equal quarterly installments thereafter, subject to continued service.

Key Details

• Transaction date: 2026-05-20; Form 4 filed 2026-05-22 (appears timely).
• Transaction type/code: Award/Grant (A).
• Shares granted: 120,074 RSUs; reported acquisition price $0.00.
• Shares owned after transaction: Not specified in the provided filing summary.
• Footnote: F1 — 1/3 vests 3/15/2027; remaining 2/3 vest in eight substantially equal quarterly installments, contingent on continued service.
• No sale or purchase of shares occurred — this is a compensation/retention grant, not an open‑market trade.

Context RSUs are a form of equity compensation that convert into shares upon vesting and are typically used for retention and aligning executive incentives with shareholders. This grant does not represent an immediate purchase or sale of stock and should be viewed as part of the CFO’s compensation program rather than a direct market signal. Tax withholding or other adjustments may apply at vesting.